ACM
TMO icon

Anfield Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Anfield Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$122K Buy
249
+135
+118% +$73.3K 0.03% 162
2025
Q4 		$66.1K Hold
114
– – 0.02% 156
2025
Q3 		$55.3K Buy
114
+4
+4% +$1.86K 0.02% 172
2025
Q2 		$44.6K Hold
110
– – 0.01% 175
2025
Q1 		$54.7K Hold
110
– – 0.02% 142
2024
Q4 		$57.2K Sell
110
-15
-12% -$8.25K 0.02% 127
2024
Q3 		$77.3K Buy
125
+15
+14% +$8.88K 0.03% 118
2024
Q2 		$60.8K Buy
+110
New +$63K 0.03% 111
2021
Q4 		– Sell
-22
Closed -$13K – 129
2021
Q3 		$13K Buy
+22
New +$12.1K ﹤0.01% 87

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Anfield Capital Management's TMO Position: Q1 2026 in Review

Anfield Capital Management increased its Thermo Fisher Scientific (TMO) stake by 118% in Q1 2026, buying an estimated $73.3K and bringing the position to 249 shares worth $122K. The position accounts for 0.03% of the portfolio, ranked #162.

Anfield Capital Management first reported a position in TMO in Q3 2021 and has held it in 9 quarters since. 2,600 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Anfield Capital Management held 249 shares of Thermo Fisher Scientific worth $122K as of Q1 2026.
  • Anfield Capital Management bought 135 Thermo Fisher Scientific shares in Q1 2026, an estimated $73.3K.
  • Thermo Fisher Scientific made up 0.03% of Anfield Capital Management's portfolio in Q1 2026, its #162 holding.
  • Anfield Capital Management first reported a position in Thermo Fisher Scientific in Q3 2021 and has held it in 9 quarters since.
  • 2,600 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Anfield Capital Management's 13F filing for Q1 2026, filed 12 May 2026.